SSPL Securities Private Limited

Saturday 26 Jul, 2025 07:34 AM

Hexaware Tech slumps after muted Q2 outcome Cipla gains after Q1 PAT rises 10% YoY to Rs 1,298 crore Shriram Finance Q1 PAT jumps 9% YoY to Rs 2,156 cr Chennai Petroleum Corporation Ltd leads losers in 'A' group Jayaswal Neco Industries Ltd leads losers in 'B' group Phoenix Mills jumps after posting steady Q1 earnings Volumes jump at Trident Ltd counter Bharat Electronics bags additional defence orders worth Rs 563 cr Saregama India Ltd down for fifth straight session Dish TV India Ltd slips for fifth straight session Emami Ltd drops for fifth straight session Triveni Turbine Ltd down for fifth straight session Suryoday SFB slumps after Q1 PAT slides 50% YoY to Rs 35 cr KFin Tech slides after Q1 PAT drops 9% QoQ to Rs 77 cr Bajaj Finserv Q1 PAT jumps 27% YoY to Rs 5,329 cr

Saravan Stocks

Hot Pursuit

Scrips, which has significant changes during the market hours.

Natco Pharma receives USFDA EIR for Hyderabad API facility

24-Jul-25 15:09 Hrs IST

The US FDA had conducted an inspection at the company's aforementioned unit from 9 June to 13 June 2025.

Post the inspection, the company received one observation in Form-483, which was classified as 'voluntary action indicated (VAI)'.

In a regulatory filing made during market hours today, Natco Pharma announced that it has received an establishment inspection report (EIR) for its API facility located in Mekaguda.

NATCO Pharma, headquartered at Hyderabad, India, develops, manufactures and distributes generic and branded pharmaceuticals, specialty pharmaceuticals, active pharmaceutical ingredients and crop protection products.

The company's consolidated net profit increased 5.3% to Rs 406.60 crore on a 14.3% jump in revenue from operations to Rs 1,221 crore in Q4 FY25 over Q4 FY24.

Shares of Natco Pharma slipped 3% to Rs 1,003.75 on the BSE.

Powered by Capital Market - Live News

Attention Investors :

Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.

Attention Investors :

Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.

Attention Investors :

KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Attention Investors :

No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

Email ID: info@ssplwealth.com Customers grievances : grievances@ssplwealth.com Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com, Mobile No: 7305522205

Hit Count : 42952277

Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified)